coteau ARQ.

OPTH

Optimi Health Corp.
$3.25
−$0.03 (0.91%) Oct 23 close
Healthcare CompareTechnicals
1M3M6M1Y2Y
-50%-36%-22%-8%+6%May 20Oct 23Aug 652w high $6.4052w low $3.04
OPTHSPY
Wall St. Highest PT $7.71 (+137.2%) Wall St. Avg PT $6.32 (+94.5%)
$3$5$7$9$11POC $5Hi $8Avg $6
Underwater Drawdown %Max DD -47.9%Current -46.5%
0.0%-47.9%
Relative Strength vs SPY-49.6% vs SPYUnderperforming
+60%0%-60%
1W
−$0.13 (3.85%)
1M
−$1.71 (34.48%)
3M
−$1.43 (30.56%)
6M
–
YTD
–
1Y
–

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street & Morningstar coverage
Wall Street consensusNo covering analysts on file for OPTH
Analyst price targetsNo target range on file
Morningstar star ratingNot rated
Checked Wall Street & Morningstar feeds · All analyst rating changes ›

Third-party ratings, not Coteau's views.

Key stats & company

Market value$18.6M
52-week range$3.04 – $6.40
Revenue growth (latest quarter vs a year ago)-28.6%
Dividend yieldNo dividend

What they do

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances.

Healthcare · Drug Manufacturers - Specialty & Generic
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for OPTH yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 Coteau Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 Coteau Physical AI Grid & Power
Outside this model's universe or screens
 Coteau Long Book
Not in the current book

Earnings & events

OPTH earningsNo upcoming date on file
Source: Yahoo Finance · refreshed 2026-10-24 03:17:42 ET
No EPS history available.

Quarterly revenue

QuarterRevenueYoY
2026-06-30$140.2K-28.6%
2026-03-31$99.5K–
2025-12-31$0–
2025-09-30$-64.0K–
2025-06-30$196.4K–

News & catalysts

More news
Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia
GlobeNewswire · Oct 20
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive · Oct 19
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive · Oct 12
Optimi Health to Present at the ThinkEquity Conference
GlobeNewswire · Oct 07
Optimi Health Appoints Melanie Pump to Board of Directors
GlobeNewswire · Sep 29

Stats refreshed 2026-10-24 03:17:42 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, Coteau model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

coteau

Free to use. No card, no ads, no auto-renew.

Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026